Efficacy of Entecavir-Tenofovir Combination Therapy for Chronic Hepatitis B Patients with Multidrug-Resistant Strains
β Scribed by Lee, Y. B.; Lee, J.-H.; Lee, D. H.; Cho, H.; Ahn, H.; Choi, W.-M.; Cho, Y. Y.; Lee, M.; Yoo, J.-J.; Cho, Y.; Cho, E. J.; Yu, S. J.; Kim, Y. J.; Yoon, J.-H.; Kim, C. Y.; Lee, H.-S.
- Book ID
- 126890904
- Publisher
- American Society for Microbiology
- Year
- 2014
- Tongue
- English
- Weight
- 930 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0066-4804
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV ΓΎ LAM therapy
## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETVβresistant H